FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-CoV-2-;the virus that causes […]
» Read moreHome »
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, […] The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results […] In an effort to understand why men are at greater risk for more severe symptoms and worse outcomes from COVID-19 […] When New York City’s Covid-19 epidemic peaked in late March and early April, the city was reporting more than 5,000 […] (HealthDay)—A combination drug therapy for COVID-19 aims to both prevent the virus from spreading inside the human body as well […] US may approve emergency use of Ebola drug remdesivir TODAY – as Oxford expert hails trial as ‘fantastic result and […]
Baricitinib plus remdesivir shows promise for treating COVID-19
Remdesivir has ‘no meaningful impact’ on COVID-19 survival, huge study finds
Estrogen may lessen severity of Covid-19 symptoms in women
Covid-19: This new coronavirus wave isn’t like the old wave
Combining remdesivir with other meds could boost COVID-fighting power
US may approve emergency use of Ebola drug remdesivir TODAY
